IL133253A0 - Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them - Google Patents

Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL133253A0
IL133253A0 IL13325399A IL13325399A IL133253A0 IL 133253 A0 IL133253 A0 IL 133253A0 IL 13325399 A IL13325399 A IL 13325399A IL 13325399 A IL13325399 A IL 13325399A IL 133253 A0 IL133253 A0 IL 133253A0
Authority
IL
Israel
Prior art keywords
sub
sup
coxr
chlorophyll
bacteriochlorophyll
Prior art date
Application number
IL13325399A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL13325399A priority Critical patent/IL133253A0/xx
Priority to HK03108847.5A priority patent/HK1056557B/xx
Priority to PCT/IL2000/000811 priority patent/WO2001040232A1/en
Priority to ES00979916T priority patent/ES2250214T3/es
Priority to DK00979916T priority patent/DK1246826T3/da
Priority to IL14987500A priority patent/IL149875A0/xx
Priority to CA002392989A priority patent/CA2392989A1/en
Priority to MXPA02005455A priority patent/MXPA02005455A/es
Priority to PL00356391A priority patent/PL356391A1/xx
Priority to JP2001540987A priority patent/JP2003515538A/ja
Priority to BR0016051-2A priority patent/BR0016051A/pt
Priority to US10/148,552 priority patent/US7169753B2/en
Priority to AU17292/01A priority patent/AU777761B2/en
Priority to DE60023748T priority patent/DE60023748T2/de
Priority to AT00979916T priority patent/ATE308545T1/de
Priority to EP00979916A priority patent/EP1246826B1/de
Priority to CNB008186030A priority patent/CN1222526C/zh
Priority to HU0204167A priority patent/HU224553B1/hu
Priority to RU2002117287/04A priority patent/RU2250905C2/ru
Publication of IL133253A0 publication Critical patent/IL133253A0/xx
Priority to NO20022599A priority patent/NO323208B1/no
Priority to US10/414,007 priority patent/US7045117B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/10Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
IL13325399A 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them IL133253A0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IL13325399A IL133253A0 (en) 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
JP2001540987A JP2003515538A (ja) 1999-12-01 2000-12-01 クロロフィル及びバクテリオクロロフィルのエステル類、その調製及びそれを含む医薬組成物
AU17292/01A AU777761B2 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
ES00979916T ES2250214T3 (es) 1999-12-01 2000-12-01 Esteres de clorofila y bacterioclorofila, su preparacion y composiciones farmaceuticas que los comprenden.
DK00979916T DK1246826T3 (da) 1999-12-01 2000-12-01 Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere
IL14987500A IL149875A0 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
CA002392989A CA2392989A1 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
MXPA02005455A MXPA02005455A (es) 1999-12-01 2000-12-01 Esteres de clorofila y bacterioclorofila, su preparacion y composiciones farmaceuticas que los contienen.
PL00356391A PL356391A1 (pl) 1999-12-01 2000-12-01 Estry chlorofilu i bakteriochlorofilu, sposób ichwytwarzania oraz zawierające je kompozycje farmaceutyczne
HK03108847.5A HK1056557B (en) 1999-12-01 2000-12-01 Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative
BR0016051-2A BR0016051A (pt) 1999-12-01 2000-12-01 ésteres clorofìlicos e bacterioclorofìlicos, sua preparação e composições farmacêuticas que os compreendem
US10/148,552 US7169753B2 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
PCT/IL2000/000811 WO2001040232A1 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, and their preparation
DE60023748T DE60023748T2 (de) 1999-12-01 2000-12-01 Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
AT00979916T ATE308545T1 (de) 1999-12-01 2000-12-01 Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
EP00979916A EP1246826B1 (de) 1999-12-01 2000-12-01 Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
CNB008186030A CN1222526C (zh) 1999-12-01 2000-12-01 制备合成的叶绿素或细菌叶绿素衍生物的酯交换的方法
HU0204167A HU224553B1 (hu) 1999-12-01 2000-12-01 Átészterezési eljárás klorofill- és bakterioklorofill C-133, C-173 diészterek előállítására
RU2002117287/04A RU2250905C2 (ru) 1999-12-01 2000-12-01 Способ трансэтерификации для получения синтетического производного хлорофилла или бактериохлорофилла
NO20022599A NO323208B1 (no) 1999-12-01 2002-05-31 Omforestringsfremgangsmate for fremstilling av klorofyll- og bakterioklorofyll-C13(3), C-17(3) diestere
US10/414,007 US7045117B2 (en) 1999-12-01 2003-04-16 Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13325399A IL133253A0 (en) 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
IL133253A0 true IL133253A0 (en) 2001-04-30

Family

ID=11073554

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13325399A IL133253A0 (en) 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them

Country Status (18)

Country Link
US (1) US7169753B2 (de)
EP (1) EP1246826B1 (de)
JP (1) JP2003515538A (de)
CN (1) CN1222526C (de)
AT (1) ATE308545T1 (de)
AU (1) AU777761B2 (de)
BR (1) BR0016051A (de)
CA (1) CA2392989A1 (de)
DE (1) DE60023748T2 (de)
DK (1) DK1246826T3 (de)
ES (1) ES2250214T3 (de)
HU (1) HU224553B1 (de)
IL (1) IL133253A0 (de)
MX (1) MXPA02005455A (de)
NO (1) NO323208B1 (de)
PL (1) PL356391A1 (de)
RU (1) RU2250905C2 (de)
WO (1) WO2001040232A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
WO2002013820A1 (en) * 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
US7715901B2 (en) 2002-05-08 2010-05-11 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CA2533129A1 (en) 2003-07-31 2005-02-10 Light Bioscience, Llc System and method for the photodynamic treatment of burns, wounds, and related skin disorders
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
CN1980661B (zh) * 2004-06-07 2011-09-28 耶达研究及发展有限公司 阳离子细菌叶绿素衍生物及其用途
MX2007000338A (es) 2004-06-09 2007-03-28 Quadra Logic Tech Inc Terapia fotodinamica para el tratamiento de trastornos hiperactivos de glandulas sebaceas.
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
RU2303966C2 (ru) * 2005-10-11 2007-08-10 Федеральное Государственное Учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию Способ снижения поверхностной дозы офтальмоаппликатора при проведении брахитерапии внутриглазных новообразований
RU2345803C2 (ru) * 2006-11-30 2009-02-10 Закрытое Акционерное Общество "Исследовательские лаборатории "РАДА-ФАРМА" Способ фотоиммунотерапии фотосенсибилизатором, активируемым волновой энергией вне организма человека
RU2336917C1 (ru) * 2007-05-29 2008-10-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУДПО РМАПО Росздрава) Способ лечения больных псориазом
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
FR2924021B1 (fr) * 2007-11-27 2010-08-13 Du Vernet Michele Eymard Composition pour le traitement de la peau par therapie photodynamique
CN101925382A (zh) * 2008-01-28 2010-12-22 耶达研究及发展有限公司 内窥镜成像光动力学治疗系统及其使用方法
DK2257309T3 (da) 2008-02-27 2020-01-20 Yeda Res And Development Company Ltd Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner
US20130289089A1 (en) 2011-01-13 2013-10-31 Jerome A. Morris Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof
DK2747763T3 (da) * 2011-08-23 2021-03-29 Yeda Res & Dev (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
KR20150030763A (ko) 2012-07-11 2015-03-20 더미라, 인코포레이티드 감광제의 국부 전달을 위한 약제학적 조성물 및 이의 이용
US10117942B2 (en) 2013-07-12 2018-11-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery
EP3442582A1 (de) * 2016-04-10 2019-02-20 Yeda Research and Development Co. Ltd Kombinationstherapien zur behandlung von krebs mit einem bakteriochlorophyllderivat
CN108341827A (zh) * 2018-02-02 2018-07-31 浙江海正药业股份有限公司 一种制备脱镁细菌叶绿素a及脱镁细菌叶绿素a酯的方法
CN108191877A (zh) * 2018-02-05 2018-06-22 云南瑞宝生物科技股份有限公司 一种从蚕沙中提取和纯化叶绿素的方法
WO2020014522A1 (en) 2018-07-12 2020-01-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same
CN111171030B (zh) * 2018-11-12 2022-11-22 浙江海正药业股份有限公司 细菌叶绿素衍生物及其制备方法
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU857139A1 (ru) * 1979-11-02 1981-08-23 Предприятие П/Я В-2343 Способ получени порфиринов,содержащих изоциклическое метилциклопентановое кольцо
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121867A1 (de) 1991-07-02 1993-01-07 Leifeld & Lemke Maschf Vorrichtung zur pruefung der dichtigkeit von mit deckeln luftdicht verschlossenen bechern
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
PL356391A1 (pl) 2004-06-28
US7169753B2 (en) 2007-01-30
CN1222526C (zh) 2005-10-12
RU2250905C2 (ru) 2005-04-27
HK1056557A1 (en) 2004-02-20
DE60023748D1 (de) 2005-12-08
HUP0204167A3 (en) 2004-08-30
ES2250214T3 (es) 2006-04-16
DE60023748T2 (de) 2006-08-03
EP1246826A1 (de) 2002-10-09
WO2001040232A1 (en) 2001-06-07
CA2392989A1 (en) 2001-06-07
JP2003515538A (ja) 2003-05-07
MXPA02005455A (es) 2002-11-29
NO20022599D0 (no) 2002-05-31
WO2001040232A9 (en) 2002-09-12
DK1246826T3 (da) 2006-01-02
BR0016051A (pt) 2002-07-23
ATE308545T1 (de) 2005-11-15
EP1246826B1 (de) 2005-11-02
NO20022599L (no) 2002-07-11
HUP0204167A2 (hu) 2003-03-28
CN1425015A (zh) 2003-06-18
US20030148926A1 (en) 2003-08-07
HU224553B1 (hu) 2005-10-28
AU1729201A (en) 2001-06-12
AU777761B2 (en) 2004-10-28
NO323208B1 (no) 2007-01-22

Similar Documents

Publication Publication Date Title
PL356391A1 (pl) Estry chlorofilu i bakteriochlorofilu, sposób ichwytwarzania oraz zawierające je kompozycje farmaceutyczne
Zhu et al. L‐Arg‐rich amphiphilic dendritic peptide as a versatile NO donor for NO/photodynamic synergistic treatment of bacterial infections and promoting wound healing
Pierce et al. Evidence for direct inhibition of dentinoclasts by a corticosteroid/antibiotic endodontic paste
GEP20022804B (en) Erythropoietin Derivatives
ES2136673T3 (es) Utilizacion del factor de crecimiento de los queratinocitos para la obtencion de medicamentos.
DE69731083T2 (de) Verfahren zur behandlung von viralen infektionen
EP1342476A3 (de) FGFR3 als Marker für mesenchymale skeletale Vorläuferzellen und Verwendung von cytoxischen Konjugaten enthaltend eine FGFR3 bindende Gruppe für die Behandlung von Tumoren des Knorpels oder des Knochens
RU94046426A (ru) Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении
WO2001038303A3 (fr) Analogues de la vitamine d
RU95110937A (ru) Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения
US20250281676A1 (en) Delivery of cells and tissues with self-assembling peptide hydrogel materials
AU6721998A (en) Therapeutic use of the smr1 protein and active derivatives thereof
CA2169173A1 (en) Methods for stimulating erythropoiesis using thrombopoietin
CA2449856A1 (en) Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
CA3188240A1 (en) Antimicrobial matrix formed from peptide hydrogels
JPH10502371A (ja) リンホトキシンを用いる癌処置法
WO1996015758A3 (en) Methods for stimulating erythropoiesis using thrombopoietin
AU5643299A (en) Humic acid and its use in the treatment of various conditions
PT941110E (pt) Utilizacao do factor 2 de crescimento dos ceratinocitos
ATE151288T1 (de) N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
CN1163218C (zh) 新型护肤化妆品
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
AU2018363797A1 (en) Composition for the treatment of intracellular bacterial infection
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения